Caffo, Orazio

Caffo, Orazio  

CIBIO (29/10/12-)  

Mostra records
Risultati 1 - 20 di 80 (tempo di esecuzione: 0.02 secondi).
Titolo Anno di pubblicazione Autori Unitn File
1730P Electronic medical record (EMR)-assisted phone follow-up (PFU) for breast cancer survivors (CS) during COVID-19 pandemic: An Italian single institution experience 1-gen-2020 Piras, Enrico MariaZanutto, AlbertoCaffo, Orazio +
A model-based framework to identify optimal administration protocols for immunotherapies in castration-resistance prostate cancer 1-gen-2022 Coletti R.Pugliese A.Lunardi A.Caffo O.Marchetti L.
A phase II study evaluating the efficacy of enzalutamide and the role of liquid biopsy for evaluation of ARv7 in mCRPC patients with measurable metastases including visceral disease (Excalibur study) 1-gen-2024 Caffo, Orazio +
A randomised clinical trial of two docetaxel regimens (weekly vs 3 week) in the second-line treatment of non-small-cell lung cancer. The DISTAL 01 study 1-gen-2004 Caffo O +
Activity of Pemetrexed on brain metastases from Non-Small Cell Lung Cancer 1-gen-2010 Caffo O +
Apalutamide in Metastatic Castration-sensitive Prostate Cancer: Results from the Multicenter Real-world ARON-3 Study 1-gen-2025 Caffo, Orazio +
Association of G8 screening tool with prognosis and survival in patients with non-small cell lung cancer: A retrospective analysis from a single institution 1-gen-2025 Veccia, AntonelloPontalti, StefanoCaffo, Orazio +
Bone health and body composition in prostate cancer: Meet-URO and AIOM consensus about prevention and management strategies 1-gen-2024 Caffo O. +
BRCA Mutations in Prostate Cancer: Prognostic and Predictive Implications 1-gen-2020 Caffo, Orazio +
Cabazitaxel Versus Docetaxel As First-Line Therapy for Patients With Metastatic Castration-Resistant Prostate Cancer: A Randomized Phase III Trial-FIRSTANA. 1-gen-2017 Caffo O +
Clinical Outcomes and Prognostic Factors in Patients With Penile Carcinoma: A Sub-Analysis From Meet-URO 23 (I-RARE) Registry Study 1-gen-2024 Caffo, Orazio +
Clinical, Diagnostic and Therapeutic Framework of mHSPC and nmCRPC: A Multidisciplinary Consensus Project of the Italian Society for Uro-Oncology (SIUrO) 1-gen-2025 Caffo, Orazio +
Clinico-Pathological Features Influencing the Prognostic Role of Body Mass Index in Patients With Advanced Renal Cell Carcinoma Treated by Immuno-Oncology Combinations (ARON-1) 1-gen-2023 Caffo O +
Comparative analysis of Denosumab and Zoledronic acid in advanced breast cancer patients receiving CDK4/6 inhibitors 1-gen-2025 Caffo O. +
Complete pathological response to pembrolizumab in pretreated pancreatic acinar cell carcinoma 1-gen-2024 Sartori, ChiaraCarbone, Francesco GiuseppeGabbrielli, ArmandoBarbareschi, MattiaCaffo, Orazio +
Concomitant Administration of VEGFR Tyrosine Kinase and Proton Pump Inhibitors May Impair Clinical Outcome of Patients With Metastatic Renal Cancer 1-gen-2024 Caffo, Orazio +
Darolutamide Maintenance in Patients With Metastatic Castration- Resistant Prostate Cancer With Nonprogressive Disease After Taxane Treatment (SAKK 08/16) 1-gen-2023 Caffo, Orazio +
Defining the Position of [177Lu]Lu-PSMA Radioligand Therapy in the Treatment Landscape of Metastatic Castration-Resistant Prostate Cancer: A Meta-analysis of Clinical Trials 1-gen-2025 Caffo, Orazio +
Development and Validation of Prognostic Model for Metastatic Castration-Resistant Prostate Cancer Patients Treated With First-Line Abiraterone or Enzalutamide 1-gen-2025 Caffo O.Veccia A. +
Docetaxel rechallenge after an initial good response in patients with metastatic castration-resistant prostate cancer 1-gen-2015 Caffo O +